Publisher
source

Newcastle University

PhD Studentship: Development of Human Lung Cancer Organoid Models to Study Anticancer Drug Response Newcastle University in United Kingdom

Degree Level

PhD

Field of study

Molecular Biology

Funding

Available

Deadline

Mar 6, 2026

Country flag

Country

United Kingdom

University

Newcastle University

Social connections

How do Bangladeshi students apply for this?

Sign in for free to reveal details, requirements, and source links.

Where to contact

Keywords

Molecular Biology
Medical Imaging
Biology
Lung Cancer
Cell Signaling
Medical Science
Cancer Therapy

About this position

[Studentship covers home fees and UKRI rate stipend (£21,805 for 2026/27).]

This PhD studentship at Newcastle University offers an exciting opportunity to contribute to the development of human lung cancer organoid models for studying anticancer drug response. The project is situated within the Newcastle Cancer Drug Discovery Group, a multidisciplinary team of cancer biologists, pharmacologists, structural biologists, and medicinal chemists. The research focuses on KRAS mutant non-small cell lung cancer (NSCLC), a prevalent and deadly form of cancer in the UK. Targeted therapies for KRAS mutant NSCLC are under active investigation, but resistance—both intrinsic and acquired—remains a significant challenge. Resistance mechanisms may involve additional mutations in the MAPK pathway or alternative signalling responses, such as those mediated by YAP.

As a PhD student, you will develop and assess NSCLC model systems, including cell lines and patient-derived organoids (PDOs). You will evaluate the efficacy of anticancer therapeutics, study cellular signalling responses, and apply genome editing tools like CRISPR to explore the underlying mechanisms of drug resistance. The project includes working with patient samples collected before and after KRAS inhibitor treatment, enabling validation of clinically relevant resistance mechanisms. You will gain hands-on experience in advanced 3D culture systems, imaging, molecular biology, CRISPR genome editing, and target discovery, positioning your research at the interface of translational biology and preclinical development.

The studentship covers home fees and provides a UKRI rate stipend of £21,805 for the 2026/27 academic year. The award duration is four years, starting in October 2026. Applicants should have a strong academic background in biological or biomedical sciences, with experience in molecular biology, cell culture, or cancer biology considered advantageous. A minimum of a 2:1 undergraduate degree or equivalent is typically required, and English language proficiency may be necessary for non-native speakers.

To apply, submit your application online via the Newcastle University postgraduate funding portal, including your CV, academic transcripts, and a personal statement. The application deadline is 6th March 2026. For further details and to access the application portal, visit the provided funding link.

Funding details

Available

What's required

Applicants should have a strong academic background in biological sciences, biomedical sciences, or a related field. Experience in molecular biology, cell culture, or cancer biology is desirable. A minimum of a 2:1 undergraduate degree or equivalent is typically required. English language proficiency may be required for non-native speakers.

How to apply

Apply online via the Newcastle University postgraduate funding portal. Prepare your CV, academic transcripts, and a personal statement outlining your suitability for the project. Ensure your application is submitted by the deadline. For more information, visit the provided funding link.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?